SOHO 2024 | Introducing molecular diagnostics to improve leukemia care in developing countries
Peter Valk, PhD, Erasmus University Medical Center, Rotterdam, The Netherlands, discusses his involvement in the International Consortium of Acute Leukemia (I-Corps) and efforts to improve leukemia treatment in developing countries. Through the introduction of next-generation sequencing (NGS), I-Corps has successfully implemented molecular diagnostics and risk stratification, particularly in Latin American countries, resulting in significant advancements in patient care. This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
